increase over control), PTL has no effect, confirming immunofluorescence results. *P<0.05 for taxol v. control (n = 3 per group). c. Immunostaining of WT FDB fibers revealed no detectable Δ2-tubulin. (n = 3 per treatment) Scale bar = 10µm. d. Immunostaining of WT FDB fibers revealed polyglutamylated MTs (DMSO, top) that were not visibly altered by PTL. Microscope settings set for the control group, and were kept constant between treatments to allow comparison. (n = 5 per treatment) Scale bar = 10µm. e. Western blots of WT FDB fibers treated with Taxol, PTL, or control (DMSO) confirmed the expression of polyglutamylated tubulin that is unaltered by treatment and verify the limited level of Δ2-tubulin. P=0.68, One-Way ANOVA (n= 3 animals per group). f. Western blots of muscle extracts derived from mdx mice treated with either vehicle or LC-1 for 3 days. While detyrosination was significantly decreased (Fig. 7c e. Immunostaining of cardiomyocytes also revealed a low to undetectable level of polyglutamylated -tubulin. This relative difference in the abundance in polyglutamylation vs. detyrosination is evident in a cardiomyocyte co-stained for detyrosinated -tubulin (pseudocolor blue). Scale bar = 10µm. f. The low abundance of polyglutamylation was verified by Western blot, where a band could be detected with taxol treatment, but only when contrast was increased to saturate GAPDH signal. Note that 3x more protein was loaded for panels b, d, and f compared to tubulin blots in Fig. 1f , as this was required to detect acetylation, Δ2, or polyglutamylation signal. h. Western blots of muscle extracts derived from mdx mice treated with either vehicle or LC-1 for 3 days. While detyrosination was significantly decreased (see Fig. 8b 
